Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis
Clinical trial NCT03236792 · COMPLETED
Trial details
- NCT number
- NCT03236792
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2022-09-20
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.